Literature DB >> 419920

The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.

W P Collins, P O Collins, M J Kilpatrick, P A Manning, J M Pike, J P Tyler.   

Abstract

Methods based upon the principles of radioimmunoassay have been developed and evaluated for the measurement of oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide in samples of unextracted urine. The procedures have been applied to daily urine (early morning fraction and combined 24 hour collections) from 6 women throughout one complete menstrual cycle and to serial samples from an additional 14 women who only collected early morning specimens. The results showed that there were characteristic, well-defined changes in the concentration of all 3 metabolites in both samples of urine and from all subjects. In addition, there was a reasonable correlation between the concentration of all 3 compounds in samples of early morning urine and the corresponding rates of excretion per 24 hours. These findings suggest that the procedures may be of value for monitoring ovarian function over long periods of time, without the problems of stress and inconvenience to the patient. Furthermore, the ratio of values for oestrone-3-glucuronide to pregnanediol-3alpha-glucuronide may be used to indicate the start and finish of the fertile period.

Entities:  

Keywords:  Biology; Clinical Research; Endocrine System; Estrogens; Estrone; Examinations And Diagnoses; Gonadotropins, Pituitary; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Menstrual Cycle; Menstruation; Ovary; Ovulation Detection; Physiology; Reproduction; Research Methodology

Mesh:

Substances:

Year:  1979        PMID: 419920     DOI: 10.1530/acta.0.0900336

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Characterization of luteal function by measuring the cumulative concentration of serum progesterone and urine pregnanediol-3 alpha-monoglucuronide.

Authors:  G Aprò; G Falkay; M Sas
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

2.  Absorption and metabolism of oral progesterone.

Authors:  M I Whitehead; P T Townsend; D K Gill; W P Collins; S Campbell
Journal:  Br Med J       Date:  1980-03-22

3.  Sulpiride and the potentiation of progestogen only contraception.

Authors:  M R Payne; P W Howie; A S McNeilly; W Cooper; M Marnie; L Kidd
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

Review 4.  The analysis of urinary hormonal steroids.

Authors:  P Vestergaard
Journal:  Lipids       Date:  1980-09       Impact factor: 1.880

5.  Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty.

Authors:  F Bassi; O Bartolini; A S Neri; R G Gheri; A Magini; S Bucciantini; V Bruni
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

6.  Towards the Clinical Evaluation of the Luteal Phase in Fertile Women: A Preliminary Study of Normative Urinary Hormone Profiles.

Authors:  María Elena Alliende; José Antonio Arraztoa; Ulises Guajardo; Fernando Mellado
Journal:  Front Public Health       Date:  2018-05-31

7.  Urinary specific gravity as an alternative for the normalisation of endocrine metabolite concentrations in giant panda (Ailuropoda melanoleuca) reproductive monitoring.

Authors:  Jella Wauters; Kirsten S Wilson; Tim Bouts; Iain Valentine; Koen Vanderschueren; Cyrillus Ververs; A Forbes Howie; Mick T Rae; Ann Van Soom; Rengui Li; Desheng Li; Hemin Zhang; Lynn Vanhaecke
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.